Buyopportunity
Gold price increase - recoveryGOLDEN INFORMATION:
Gold price (XAU/USD) holds steady near $5,190 during the early Asian session on Wednesday. The precious metal steadies after a period of volatility following signals of potential de-escalation in Middle East tensions.
US President Donald Trump said on Monday that US military operations in Iran would be ending soon but gave no clear timeline for halting attacks that have rattled the Middle East and global markets. His latest comments on the Middle East war dragged oil prices lower and eased inflationary concerns, which provided some support to the yellow metal.
⭐️Personal comments NOVA:
Gold prices broke out of the sideways trading range of 5200, maintaining upward momentum and continuing towards a higher resistance level of 5262.
⭐️SET UP GOLD PRICE
🔥SELL GOLD zone: 5262 - 5264 SL 5269
TP1: $5245
TP2: $5220
TP3: $5200
🔥BUY GOLD zone: 5159- 5157 SL 5152
TP1: $5170
TP2: $5189
TP3: $5210
⭐️Technical analysis: Based on technical indicators EMA 34, EMA89 and support resistance areas to set up a reasonable BUY order.
⭐️NOTE:
Note: Nova wishes traders to manage their capital well
- take the number of lots that match your capital
- Takeprofit equal to 4-6% of capital account
- Stoplose equal to 2-3% of capital account
$BNTX The Founders Left. The Pipeline Didn't.This morning BioNTech dropped a bombshell. Co-founders Prof. Ugur Sahin and Prof.
Özlem Türeci, the two scientists who built the mRNA platform that produced the world's first approved COVID-19 vaccine, announced they are leaving the company by end of 2026 to start a new independent mRNA-focused biotech.
BioNTech will contribute related mRNA technology rights to the new venture in exchange for a minority stake and potential milestones and royalties. The stock immediately sold off 14%, wiping approximately $4.26 billion from the company's market cap in a single session.
The market treated this like an existential event. It is not.
Here is what did not leave with the founders:
15 ongoing Phase 3 oncology trials with multiple late-stage readouts expected in 2026.
A completed acquisition of CureVac in December 2025, expanding BioNTech's mRNA manufacturing and IP portfolio significantly. Positive Phase 2 data from pumitamig in triple-negative breast cancer. A new HIV antibody trial adding depth to the long-term infectious disease pipeline.
A new first-in-human BNT3214 cancer trial initiated this week. A new mpox mRNA vaccine trial launched in Africa. Morgan Stanley maintaining its Buy rating. HC Wainwright maintaining a $140 price target. JP Morgan maintaining $120. UBS at $117. Analyst median target sitting at $131. A strong cash position that management highlighted at the JP Morgan conference in January.
A stated goal of becoming a commercial multi-product oncology company by 2030. The binding agreement for the founders' new venture is not even signed yet, it is expected by end of H1 2026, and the transition does not complete until end of 2026.
The company has time to install new leadership and the pipeline is already in motion.
Now add the Iran war layer. Every modern conflict accelerates biodefense spending.
The US military and allied governments have dramatically increased investment in rapid-response vaccine and therapeutic platforms since COVID-19. BioNTech's mRNA technology is the most validated rapid-response platform on the planet, capable of producing a new vaccine candidate in weeks.
In a conflict environment where biological threats, chemical exposure, and mass casualty scenarios demand fast medical countermeasures, BioNTech's platform is not a liability.
It is infrastructure. Biodefense investment is rising globally and mRNA sits at the center of every serious government preparedness program.
The weekly chart puts this in full context. After a multi-year downtrend from the COVID highs above $400, BioNTech built a long base through 2023 and 2024, broke out hard into late 2025, hit $124 on the 52-week high, and has now retraced sharply back into the prior breakout zone.
Today's founder news accelerated that pullback into two clean weekly demand zones that sit directly on long-term Fibonacci support levels. The red SMA 200 is still declining as overhead resistance but the green SMA 20 is trying to curl at a historically significant horizontal level.
🟢 Buy Zone 1 ($65.92 area)
Price has been driven into the 0.618 Fibonacci retracement of the entire 2024 to 2025 breakout move. The weekly candle is printing a long lower wick as institutional buyers absorb the panic selling. This is the first high-probability demand zone with a defined stop below the prior consolidation base.
Stop: $2.50 below entry (3.792%) / $45,000 position
Qty: 2,000
Risk/Reward Ratio: 11.94
Target: +45.297% ($95.78 area / $109,720)
🟢 Buy Zone 2 ($51.17 area)
If broader market risk-off and continued founder transition uncertainty pushes BNTX toward the 0.786 Fibonacci level and the lower boundary of the multi-year base, this is the entry with maximum R/R before a full trend reversal would be confirmed.
Stop: $2.50 below entry (4.886%) / $45,000 position
Qty: 2,000
Risk/Reward Ratio: 11.94
Target: +58.355% ($81.17 area / $109,720)
Key Levels:
🔑 Current Price: $83.40
🔑 Buy Zone 1: ~$65.92 area
🔑 Buy Zone 2: ~$51.17 area
🔑 52-Week Low: $76.53
🔑 52-Week High: $124.00
🔑 HC Wainwright Target: $140.00
🔑 Morgan Stanley Target: $131.00
🔑 JP Morgan Target: $120.00
🔑 Analyst Median Target: $131.00
🔑 Phase 3 Trials: 15
🎯 Target: $113 (+45% from Zone 1 / $109,720)
⚠️ Hard Stop Both Zones: $2.50 below entry
The founders built the platform. The platform is what has value now. Fifteen Phase 3 oncology trials do not stop running because the people who started the company are moving on.
The CureVac acquisition does not unwind. The mRNA IP does not disappear. The biodefense contracts do not evaporate. What changed today is sentiment, and sentiment at panic lows on a weekly demand zone is where the setups are made.
The founders left. The pipeline didn't. That is the trade.
If you found this analysis valuable, hit the Follow button at the top of the page. Every idea in this Iran war series, oil, defense, reconstruction, crypto, chips, cyber, AI infrastructure, domestic manufacturing, flash storage, AI data centers, and now biodefense mRNA, is being updated in real time as the conflict develops. You don't want to miss what's coming next.
AUDCAD Bullish Trade IdeaA long trade opportunity recently presented itself on the Aussie-Loonie trading chart, following a breakout of a bearish order block.
Price, thereafter, pulled back and retested the bearish order block (now acting like a bullish order block, more like a support to push price higher) by forming a bullish harami candlestick pattern just above the highest level of the same order block.
This confirms a continuation of the uptrend.
ICT Liquidity Sweep & High-Probability Reversal SetupPrice is reacting from the marked support zone after a strong sell-off, suggesting buyers are stepping in at a key demand area 📈. An ICT-style liquidity sweep toward the London Low may occur to grab sell-side liquidity before a true bullish expansion begins 🔄🏦. This sweep can create the fuel needed for a stronger reversal.
If support holds and a clear bullish confirmation (like CHoCH or displacement) appears, the upside target remains the OB zone 🎯. Maintain strict risk management—define your stop loss below the sweep level and protect capital while aiming for a strong risk-to-reward setup ⚖️💰🚀.
TEJASNET- BUY - HIGH RISKPlease stick to levels provided on the chart.
Evaluate possible loss, before venturing into the idea.
Markets are volatile and could result in sharp up and down moves, so please avoid, if u are strictly looking at from a trading perspective, since the buy involves some holding period.
Gold prices rise - gold continues to recover.GOLDEN INFORMATION:
Gold is on fire at the start of the week, a widely expected move, as investors seek harbor in the traditional store of value, following the continued US and Israel attacks on Iran.
The bright metal opened with a bullish gap of about $17 and rallied toward the $5,400 level as Asian traders hit their desks and reacted negatively to the weekend news of the Middle East conflict, rushing for cover in Gold.
⭐️Personal comments NOVA:
With military tensions rising over the weekend, gold prices clearly benefited, recovering to around 5400.
⭐️SET UP GOLD PRICE
🔥SELL GOLD zone: 5448 - 5450 SL 5455
TP1: $5420
TP2: $5400
TP3: $5380
🔥BUY GOLD zone: 5244- 5246 SL 5239
TP1: $5260
TP2: $5280
TP3: $5300
⭐️Technical analysis: Based on technical indicators EMA 34, EMA89 and support resistance areas to set up a reasonable BUY order.
⭐️NOTE:
Note: Nova wishes traders to manage their capital well
- take the number of lots that match your capital
- Takeprofit equal to 4-6% of capital account
- Stoplose equal to 2-3% of capital account
$NFLX 80% move incoming?After tapping the 200 EMA, NFLX showed no signs of panic selling, instead, price stabilized and began printing higher lows, suggesting absorption rather than distribution. This zone acted as a liquidity pocket where weak hands likely exited and stronger participants accumulated positions. The recent compression beneath resistance signals building pressure, and a decisive daily close above the range high could trigger a momentum expansion phase fueled by short covering and trend-following flows. I’m not blindly predicting an 80% move, but structurally this is how larger upside legs begin, reclaim trend, build cause, then expand. Invalidation remains a sustained close back below the 200 EMA, which would shift the narrative back to distribution. Until then, this looks like early-stage positioning rather than late-stage chasing.
Accumulation and price increase - back to 5246GOLDEN INFORMATION:
Gold price (XAU/USD) tumbles to near $5,140, snapping the four-day winning streak during the early Asian session on Wednesday. The precious metal loses momentum amid some profit-taking and a stronger US Dollar (USD). Traders will closely monitor the US President Donald Trump's State of the Union address on Wednesday for clarity on fiscal policies.
After reaching multi-week highs, traders start booking their profits, weighing on the yellow metal. Furthermore, hawkish comments from the US Federal Reserve (Fed) officials underpin the Greenback and drag the USD-denominated commodity price lower. Boston Fed President Susan Collins said on Tuesday that interest rates are likely to stay unchanged “for some time” as recent economic data shows an improvement in the labor market, while risks to inflation remain, per Bloomberg.
⭐️Personal comments NOVA:
After gaining sufficient liquidity around the 5110 gap, the price of gold continued to rise and recovered above 5200.
⭐️SET UP GOLD PRICE
🔥SELL GOLD zone: 5245 - 5247 SL 5252
TP1: $5230
TP2: $5210
TP3: $5190
🔥BUY GOLD zone: 5045- 5043 SL 5038
TP1: $5060
TP2: $5075
TP3: $5100
⭐️Technical analysis: Based on technical indicators EMA 34, EMA89 and support resistance areas to set up a reasonable BUY order.
⭐️NOTE:
Note: Nova wishes traders to manage their capital well
- take the number of lots that match your capital
- Takeprofit equal to 4-6% of capital account
- Stoplose equal to 2-3% of capital account
Microsoft Opportunity Microsoft is trading at a forward P/E of about 24x, which is near its 10-year low. For a company growing revenue at 17%, this is considered "cheap" by historical standards.
Despite the stock drop, Microsoft actually beat earnings and revenue expectations. The core business (Office 365, Azure, LinkedIn) is still incredibly healthy.
X A U U S D : (Buy Stop - 5074.212)Gold - carrying on with its (up trend) (5074.212) - (Buy Stop level), this is a potential buy zone and buy stop level to help carry up the price to the highs of the structure and trend , make sure to trade accordingly and use (Proper Risk Management & Take Partials) when necessary
BTC : (68K RECAP & PARTIALS)Btcusd performance has been impressive as it hit the (Daily High Price) of (68K) before tanking down , for this trade if a (Trail Stop & Partial Close) method was used as suggested in the previous (Btc Post) then it’s guaranteed profits or (Break Even, depending on if the (SL) was adjusted accordingly and to the trading plan and rules
(Daily Price High - 68310.29)
TheGrove | GBPUSD buy | Idea Trading AnalysisGBP/USD is trading within a rising channel, with price holding above the ascending line after a clear bullish and is moving on Resistance level.
We expect a decline in the channel after testing the current level.
We expect a decline in the channel after testing the current level
Hello Traders, here is the full analysis.
I think we can soon see more fall from this range! GOOD LUCK! Great BUY opportunity GBPUSD
I still did my best and this is the most likely count for me at the moment.
-------------------
Traders, if you liked this idea or if you have your own opinion about it, write in the comments. I will be glad ⚜️






















